Why the study?
Does methacholine challenge reveal differences in hemodynamic reactivity in normotensives with a genetic risk of hypertension compared to controls?
Does methacholine challenge reveal differences in hemodynamic reactivity in normotensives with a genetic risk of hypertension compared to controls?
Normotensive individuals with a genetic risk of hypertension exhibit an exaggerated secondary blood pressure rise to methacholine, suggesting heightened sympathetic reactivity.
Answers are grounded in this paper and cite their sources.
Should not yet change risk stratification in normotensives; leaves open whether methacholine reactivity predicts future hypertension.
Hemodynamic reactivity to methacholine (0,1 mg/kg bodyweight) was studied in 10 normotensives with genetic risk of hypertension (mean age: 25,4 +/- 2,6 years) in comparison with 8 controls (mean age: 25,0 +/- 2,3 yrs). Due to peripheral vasodilatation this substance led to an initial blood pressure fall which was the same in the investigated and in the control group. In the phase of counterregulation the secondary rise of blood pressure was higher in the group with family history of hypertension. As evidenced by correlation statistical analysis the increases of heart rate and cardiac output were responsible for the rise of systolic blood pressure. The hemodynamic response to methacholine in the group with genetic risk of hypertension has been attributed to a higher sympathetic reactivity.
No takes yet. Share an insight, caveat, or question.
Schulte et al. (1984) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: